ArticleBMC plant biology2026
Systematic characterization of the R2R3-MYB family in Lithospermum erythrorhizon and regulatory mechanisms of LeMYB1 in shikonin biosynthesis.
Article in BMC plant biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Lithospermum erythrorhizon is a medicinal plant valued for its ability to produce shikonin and its derivatives, a compound with important pharmacological properties. While R2R3-MYB transcription factors are known regulators of plant metabolism, no genome-wide analysis had been conducted in L. erythrorhizon. In this study, we present the comprehensive identification and evolutionary study of R2R3-MYBs in L. erythrorhizon, characterizing 176 LeMYB genes. Structural and conserved motif analyses revealed that the R2 and R3 domains of LeMYBs are relatively conserved, while sequence diversity has progressively emerged during evolution. Phylogenetic analysis classified the LeMYBs into 31 subfamilies, expanded mainly through whole-genome duplication, transposed duplication, and dispersed duplication. Expression profiling identified that certain LeMYBs exhibit root/leaf/flower-specific expression, with LeMYB1 predominantly expressed in roots, showing a 63-fold increase in transcript levels compared to leaves and significant upregulation under shikonin-inducing conditions. Subcellular localization confirmed that LeMYB1 is a nucleus-localized protein. Finally, yeast one-hybrid (Y1H) and dual-luciferase reporter assays collectively demonstrate that LeMYB1 binds to the promoters of key shikonin biosynthetic enzyme genes (LeHMGR2, LeGPPS1, LePGT1, LeGHQ3''H2, and LeSAT1) and activates their transcription, thereby promoting shikonin biosynthesis. This study provides the first genome-wide evolutionary analysis of R2R3-MYBs in L. erythrorhizon and reveals that LeMYB1 coordinately regulates multiple shikonin biosynthetic genes, laying the foundation for elucidating the regulatory mechanisms of shikonin biosynthesis and for mining potential transcription factors for genetic improvement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.